We are dedicated to developing transformative therapies for patients with fibrotic disease.
We believe that AX-202 has the potential to transform how fibrosis is treated and help many patients poorly served by current therapeutic options.
Arxx Therapeutics
in Norway: Gaustadalléen 21, 0349 Oslo
in Denmark: Symbion Science Park, Fruebjergvej 3, 2100 Copenhagen
© 2021 Arxx Therapeutics. All rights reserved. |
Privacy Policy